Literature DB >> 3038760

Peripheral benzodiazepines enhance the respiratory burst of macrophage-like P388D1 cells stimulated by arachidonic acid.

F Zavala, M Lenfant.   

Abstract

P388D1, a murine cell with macrophage properties, responds to exogenous arachidonic acid with superoxide anion production. This oxidative burst is enhanced by peripheral and mixed type benzodiazepines and this stimulation is specifically reversed by the peripheral antagonist PK 11195. In contrast, PK 11195 is unable to antagonize a stimulation caused by a non-benzodiazepine ligand such as the chemotactic peptide fMet-Leu-Phe. The optimal concentrations were close to 10 nM and corresponded to the affinities of the compounds for the peripheral benzodiazepine receptor detected on these cells. Compared to other tissues where peripheral benzodiazepines acted only at micromolar concentrations, the macrophage with its functional receptor appears as a privileged site of action for these molecules.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3038760     DOI: 10.1016/0192-0561(87)90050-6

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  3 in total

Review 1.  Molecular mechanisms of peripheral benzodiazepine receptors.

Authors:  S H Snyder; M W McEnery; A Verma
Journal:  Neurochem Res       Date:  1990-02       Impact factor: 3.996

2.  Early developmental exposure to benzodiazepine ligands alters brain levels of thiobarbituric acid-reactive products in young adult rats.

Authors:  R C Miranda; J P Wagner; C K Kellogg
Journal:  Neurochem Res       Date:  1989-11       Impact factor: 3.996

3.  In vitro evaluation of the anti-leishmanial activity and toxicity of PK11195.

Authors:  Carlos Eduardo Sampaio Guedes; Beatriz Rocha Simões Dias; Antonio Luis de Oliveira Almeida Petersen; Kercia Pinheiro Cruz; Niara de Jesus Almeida; Daniela Rodrigues Andrade; Juliana Perrone Bezerra de Menezes; Valéria de Matos Borges; Patricia Sampaio Tavares Veras
Journal:  Mem Inst Oswaldo Cruz       Date:  2018-02-05       Impact factor: 2.743

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.